MiSight 1 day

The first and only FDA-approved soft contact lens clinically proven to slow the progression of myopia (nearsightedness) in children aged 8-12 at initiation of treatment. Uses ActivControl Technology with dual-focus optical design that simultaneously corrects vision and creates myopic defocus to slow eye elongation. Daily disposable for optimal hygiene. Clinical studies showed 59% reduction in myopia progression over 3 years.